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Abstract
The ethanolic extract from Rhodomyrtus tomentosa leaf exhibited good antibacterial activities against both methicillin-
resistant Staphylococcus aureus (MRSA) and S. aureus ATCC 29213. Its minimal inhibitory concentration (MIC) values ranged
from 31.25–62.5 mg/ml, and the minimal bactericidal concentration (MBC) was 250 mg/ml. Rhodomyrtone, an
acylphloroglucinol derivative, was 62.5–125 times more potent at inhibiting the bacteria than the ethanolic extract, the
MIC and MBC values were 0.5 mg/ml and 2 mg/ml, respectively. To provide insights into antibacterial mechanisms involved,
the effects of rhodomyrtone on cellular protein expression of MRSA have been investigated using proteomic approaches.
Proteome analyses revealed that rhodomyrtone at subinhibitory concentration (0.174 mg/ml) affected the expression of
several major functional classes of whole cell proteins in MRSA. The identified proteins involve in cell wall biosynthesis and
cell division, protein degradation, stress response and oxidative stress, cell surface antigen and virulence factor, and various
metabolic pathways such as amino acid, carbohydrate, energy, lipid, and nucleotide metabolism. Transmission electron
micrographs confirmed the effects of rhodomyrtone on morphological and ultrastructural alterations in the treated bacterial
cells. Biological processes in cell wall biosynthesis and cell division were interrupted. Prominent changes including
alterations in cell wall, abnormal septum formation, cellular disintegration, and cell lysis were observed. Unusual size and
shape of staphylococcal cells were obviously noted in the treated MRSA. These pioneer findings on proteomic profiling and
phenotypic features of rhodomyrtone-treated MRSA may resolve its antimicrobial mechanisms which could lead to the
development of a new effective regimen for the treatment of MRSA infections.
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Introduction
Staphylococcus aureus is well-evidenced as a major human pathogen.
The organism commonly involves in skin and soft tissue infections
such as pimples, boils, furuncles, cellulites, folliculitis, impetigo,
carbuncles,scalded skinsyndrome, and abscesses. In addition, it can
cause some serious infections including bacteremia, pneumonia,
acute endocarditis, meningitis, osteomyelitis, toxic shock syndrome,
and fatal invasive diseases [1]. The emergence and spread of
methicillin-resistant S. aureus (MRSA) originated in the 1960s as an
important clinical and epidemiological problem in hospital
environments. Additionally, S. aureus has been a crucial cause of
community-acquired infections which may result in morbidity and
mortality [2,3]. The introduction of glycopeptide antibiotics, a last
resort to treat such infections, was followed by the isolation of either
vancomycin-intermediate S. aureus (VISA) or vancomycin-resistant
S. aureus (VRSA) [4,5].
Several active researches have documented new antibiotics and
semi-synthetic analogs with improved antimicrobial properties
[6,7,8]. Various plants worldwide have been used in traditional
medicine as alternative treatments of bacterial infections [9,10,11].
Rhodomyrtone, an acylphloroglucinol derivative isolated from the
leafofRhodomyrtustomentosa(Aiton) Hassk., has beenbrieflyreported to
produce antibacterial effects against Escherichia coli and S. aureus [12].
From our preliminary studies, the data suggested that the ethanolic
extract of R. tomentosa and rhodomyrtone presented strong antimi-
crobial activity against a wide range of Gram-positive bacteria suchas
Bacillus subtilis, Enterococcus faecalis, S. aureus, S. epidermidis,a n d
Streptococcus spp. [13,14,15]. In addition, rhodomyrtone also exhibited
significant antimicrobial activity against S. epidermidis biofilm-forming
and S. pneumoniae capsule-producing strains [15].
In recent years, two dimensional gel electrophoresis (2DE)
reference maps of cellular or extracellular proteins from various S.
aureus strains in different growth conditions have been established
[16,17,18]. The identification of cell surface, cell membrane, and
cytoplasmic proteome map of S. aureus provides essential tool for
better understanding of biological, pathological, and physiological
significance of the bacteria. Furthermore, using 2DE separation
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spectrometry, the global view of the synthesis and distribution of
various S. aureus protein networks was obtained [16,19]. To
provide insights into the antibacterial mechanisms of this potential
antibacterial drug, proteomic technologies were used to investigate
the effects of rhodomyrtone on protein expression in treated
MRSA cells. Achievements in protein analysis have been acquired
by the combination of mass spectrometry techniques and
bioinformatic tools. The effects of rhodomyrtone on morpholog-
ical and ultrastructural changes in the treated staphylococcal cells
were further elucidated using transmission electron microscopy.
Results and Discussion
Determination of antibacterial activity of ethanolic
extract of R. tomentosa and rhodomyrtone
The efficacy of most current antibiotics for treatment of
staphylococcal infections has become quite limited due to the
occurrence of multiple resistant strains [20]. In very recent studies,
several new compounds from natural products and their
derivatives have been extensively studied to treat resistant S. aureus
[21,22,23]. A clinical MRSA isolate, NPRC 001R, was found to
be resistant to several classes of antibiotics including b-lactam,
aminoglycoside, tetracycline, macrolide, fluoroquinolone, and
clindamycin. Therefore, it has been used as a representative
isolate throughout this study. In order to assess the antibacterial
potency of ethanolic extract of R. tomentosa and rhodomyrtone on
S. aureus, susceptibility test using broth microdilution was
employed. The ethanolic extract exhibited good antibacterial
activities against both MRSA and S. aureus ATCC 29213. Its
minimal inhibitory concentration (MIC) values were 31.25–
62.5 mg/ml, and the minimal bactericidal concentration (MBC)
was 250 mg/ml. Rhodomyrtone was 62.5–125 times more potent
at inhibiting both MRSA and S. aureus ATCC 29213 than the
crude extract, its MIC and MBC values were 0.5 mg/ml and 2 mg/
ml, respectively.
Time-kill assay
Time-kill kinetic was carried out with MRSA isolates. Viable
cell counts of the bacteria after treatment with rhodomyrtone were
similar. The results of the time-kill assay of a representative isolate
were shown in Figure 1. Within 4–5 h, the bacterial growth was
stable at initial inoculum after treated at 0.125, 0.25, 0.5, 1, and
2MIC of rhodomyrtone. The number of viable cells after exposure
to MIC and 2MIC of rhodomyrtone decreased by two log-fold,
compared to the control within 18 h.
Protein variation between cells cultured in the presence
or the absence of rhodomyrtone
To preliminary address whether rhodomyrtone affected staph-
ylococcal cell protein patterns, SDS-PAGE and Western immu-
noblotting were performed. Subinhibitory concentration of
rhodomyrtone at 0.174 mg/ml (0.35MIC) was used to allow the
bacterial growth at approximately 5610
7 cfu/ml after incubation
for 18 h. Rhodomyrtone-treated staphylococcal cells exhibited
several protein bands with increase or decrease in intensity,
compared with the untreated controls. The expression of up- and
down-regulated proteins was further assessed by immunoblot
probed with mouse anti-S. aureus antisera. The protein patterns
observed after immunoblotting clearly confirmed SDS-PAGE that
both the extract and rhodomyrtone disturbed the profiles of
immunogenic S. aureus cellular proteins in MRSA and S. aureus
ATCC 29213 (data not shown). To characterize the effect of
rhodomyrtone on whole-cell protein expression in MRSA, we
further identified cellular proteins that appeared or disappeared
following the exposure to 0.35MIC rhodomyrtone at 0.174 mg/ml
in CAMHB for 18 h by 2DE in combination with mass
spectrometry. Image analysis of 2DE patterns was performed by
ImageScannerII and ImageMaster
TM Software. Most of the
protein spots were observed in acidic range as illustrated in
Figures 2A and 2B. The mapping of cellular protein expression in
MRSA revealed distinct alterations between the two proteomes. A
total of 380 MRSA protein spots were observed in the cultures
after treatment with rhodomyrtone while 301 spots were detected
in cells grown in compound-free cultural media. Of these, 203
spots were shared (unchanged expression) between the two protein
profiles. The investigation was focused on the more/less intense
proteins. Of the overexpressed or downregulated protein spots in
rhodomyrtone-treated MRSA, 18 proteins that presented only in
rhodomyrtone treated-sample and 28 proteins that disappeared
after the treatment were the proteins of interest. The presence or
the absence of protein spots in the treated MRSA proteomes were
denoted in Figures 2A and 2B. Protein spot number, protein
annotation, functional category (NCBI database) are listed in
Tables 1 and 2. The potential roles of these proteins are discussed
below.
The presence of rhodomyrtone in MRSA cultures remarkably
induced the expression of some general metabolic pathway related
proteins based on their functions. Three proteins including D-
fructose-6-phosphate amidotransferase, CTP synthetase, and
bifunctional 3-deoxy-7-phosphoheptulonate synthase/chorismate
mutase in amino acid metabolism and three proteins involved in
carbohydrate metabolism such as aconitate hydratase, pyruvate
oxidase, and malate:quinone oxidoreductase were identified. Two
other proteins including coenzyme A disulfide reductase and
pantothenate metabolism flavoprotein that related in cofactor
metabolism were noted.
F0F1 ATP synthase subunit a was induced after treatment. The
protein is partly embedded in the cell membrane and required for
the regeneration of ATP from during the transfer of protons down
the electrochemical gradient [24]. Protein members of chromo-
some partition, cell wall metabolism, and cell division such as
endo-1, 4-b-glucanase and tRNA (uracil-5-)-methyltransferase Gid
also up-regulated. Increase in the expression of three membrane
transport systems-related proteins including phosphoenolpyruvate-
protein phosphatase, ATP-binding protein Mrp-like protein, and
glycine betaine/carnitine/choline ABC transporter, an osmopro-
tectant transport system permease protein involves in osmotic
adjustment in bacteria [25], were observed.
Polynucleotide phosphorylase/polyadenylase (PNPase) was also
up-regulated in rhodomyrtone-treated MRSA. This is an enzyme
conserved in both bacteria and eukaryotic organelles that play
roles in catalyzation of the phosphorolysis of RNA, releasing
nucleotide diphosphates, and the reverse polymerization reaction.
PNPase seems also to be participated in the control of several
processes such as mRNA decay [26], cold shock response [27],
and the post-transcriptional modification [28] of mRNAs in a
variety of prokaryotes. The induction of transcription related
proteins including transcription elongation factor NusA and
elongation factor P, which are associated in protein biosynthesis
were noted after the treatment. The bacteria may utilize these up-
regulated proteins to compensate for the decrease in cell metabolic
activities and to provide more efficient response to high-osmolarity
stress due to rhodomyrtone challenge.
Rhodomyrtone inhibited the synthesis of six proteins function-
ing in glycolysis metabolic pathway such as fructose-1, 6-bispho-
sphate aldolase, pyruvate kinase, glyceraldehyde 3-phosphate
dehydrogenase 2, D-lactate dehydrogenase, dihydrolipoamide
Rhodomyrtone Affects Cellular Proteomes of MRSA
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proteins have been reported to be participated with chromosome
partition such as GTPase ObgE [29], cell wall biosynthesis, cell
division, and cell wall turnover including cell wall biosynthesis
protein ScdA [30], tubulin-liked FtsZ [31], and autolysin [32].
In bacteria, the of the cell wall is composed of the cross-linked
polymer peptidoglycan, also known as murein. Peptidoglycan
architecture consists of a disaccharide backbone built of
alternating b-1-4-N-acetylglucosamines and N-acetylmuramic
acids [33]. In S. aureus, the tetrapeptide chains allow the formation
of peptide cross-bridge including L-alanine, D-isoglutamine, L-
lysine, and D-alanine, which are attached to the N-acetylmuramic
acid. This cross-linking of peptide cross-bridge is made up of five
glycines [33]. Bacteria with compact peptidoglycan produce cell
wall hydrolase, N-acetyl-glucosaminidase, N-acetylmuramidase,
and endopeptidase for cell division [34]. It has been observed
that rhodomyrtone suppressed the expression of autolysin with
bifunctional activities, N-acetylmuramyl-L-alanine-amidase and N-
acetylglucosaminidase. The bacterial cell division machinery is
triggered with a formation of Z ring which consists of polymers of
FtsZ protein at the division site [35]. FtsZ is the bacterial tubulin
homologue which plays a key role for the recruitment of other
proteins to the cell division septum [36]. The reduction of the cell
wall-related proteins (GTPase ObgE, ScdA, FtsZ) following
treatment with rhodomyrtone likely contributes to the reduced
rate of cell wall biosynthesis, cell division, and cell wall
Figure 1. Time-kill curves of rhodomyrtone against MRSA. Viability was counted at the indicated time points by serial dilution plating. Each
point represented the mean of log10 6 standard deviations of three different experiments performed in duplicate.
doi:10.1371/journal.pone.0016628.g001
Figure 2. Two dimensional electrophoresis of the of cellular methicillin-resistant S. aureus proteomes. Protein extracts were prepared
from rhodomyrtone-treated cells (A) and untreated control cells (B).
doi:10.1371/journal.pone.0016628.g002
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of autolysin might be the result as the bacterial cells react to
prevent the destruction of peptidoglycan by autolytic enzymes.
However, many of the enzymes involved in cell wall synthesis were
not covered by the 2DE approach. An important challenge for our
further studies will be to validate distinct alterations and clarify
changes in gene expression following rhodomyrtone treatment.
Thus, DNA microarray experiments would be extremely helpful to
study effects on the transcription of genes involved in these
processes, to provide more insight in potential mode of actions of
rhodomyrtone.
A number of enzymes related in metabolism of some amino
acids such as ornithine carbamoyltransferase and arginase in
arginine biosynthesis, alanine dehydrogenase in alanine biosyn-
thesis, glycine dehydrogenase subunit 2 (decarboxylating) and 2-
amino-3-ketobutyrate coenzyme A ligase in glycine, serine, and
threonine biosynthesis, formimidoylglutamase in histidine biosyn-
thesis, and glutamine-ammonia ligase in glutamine biosynthesis
were down-regulated. Other enzymes in several amino acid and
energy metabolism were down regulated by subinhibitory
concentration of rhodomyrtone were (i), cysteine synthase (O-
acetylserine sulfhydrylase)-like protein which related with three
metabolic pathways including cysteine, seleno amino acid, and
sulfur metabolism; (ii), carbamate kinase in four metabolic
pathways including purine, glutamate, arginine and proline, and
nitrogen metabolism; and (iii), putative N-acetyltransferase. The
reduction of alanine, glycine, and glutamine expression in
rhodomyrtone-treated MRSA may be associated with the decrease
in protein and peptidoglycan synthesis since those amino acid are
crucial in both biological processes [37,38]. Particularly, the lower
glycine content which is an amino acid composition of
peptidoglycan cross-bridges might excite the aberrant cell septum
formation and retard cell division [39].
Other proteins involved in protein degradation, oxidative stress,
putative hydrolase, and hypothetical protein were also inhibited
after treatment. The stress response proteins were evidenced by
the suppressing of the expression of heat-shock proteins including
DnaK, ATP-dependent Clp protease proteolytic subunit-like
protein, and oxidative stress-related protein such as superoxide
dismutase. The proposed stress-related protein obviously reflected
an adaption of the bacteria to survival under stress condition. In S.
aureus, Clp proteins play significant roles in the regulation of many
Table 1. Identification of Staphylococcus aureus cellular proteins presented after rhodomyrtone treatment.
Spot no. Accession no. Identified proteins Mw pI Mascot Sequence
(KDa) score coverage (%)
Amino acid metabolism
18 gi|21283809 D-fructose-6-phosphate amidotransferase 65925 4.93 460 17
20 gi|15925117 CTP synthetase 60297 5.00 191 8
94 gi|15924727 bifunctional 3-deoxy-7-phosphoheptulonate 40709 5.83 266 16
synthase/chorismate mutase
Carbohydrate metabolism
4 gi|15924340 aconitate hydratase 99136 4.80 139 21
17.1 gi|15925529 pyruvate oxidase 63932 6.88 332 14
88 gi|15925597 malate:quinone oxidoreductase 56135 6.12 701 34
Cell wall metabolism
58.1 gi|15925445 endo-1,4-b-glucanase 39212 5.21 326 16
Cell division
84 gi|15924241 tRNA (uracil-5-)-methyltransferase Gid 48515 5.57 1012 40
Cofactor metabolism
90 gi|15923960 coenzyme A disulfide reductase 49374 5.28 453 21
93.2 gi|15924201 pantothenate metabolism flavoprotein 44171 5.68 60 4
Energy metabolism
26 gi|15925095 F0F1 ATP synthase subunit a 54608 4.91 595 18
Nucleotide metabolism
10 gi|15924264 polynucleotide phosphorylase/polyadenylase 77428 4.89 1533 42
Protein degradation
9 gi15925538 ATP-dependent Clp proteinase chain 77926 4.83 1256 33
Transcription
32 gi|15924256 transcription elongation factor NusA 43787 4.60 267 14
75 gi|15924518 elongation factor P 20541 4.75 263 23
Transport system membrane
17.2 gi|15924074 phosphoenolpyruvate-protein phosphatase 63394 4.62 266 11
58.2 gi|15925155 ATP-binding protein Mrp-like protein 38334 5.29 86 3
93.1 gi|15925438 glycine betaine/carnitine/choline ABC transporter 46463 5.93 108 5
doi:10.1371/journal.pone.0016628.t001
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expression, heat stress tolerance, protein degradation, and protein
folding as molecular chaperones [40,41]. In addition, they also
related to various biological processes such as cell division,
development of sporulation, genetic competence, and quality
control of protein translation [42,43]. Clp proteinase are
composed of two distinct subunits, proteolytic part is assembled
with ATPase subunit into a multimeric structure. In E. coli, Clp
protease is known to play a role in cytoplasmic quality control and
participate in numerous regulatory mechanisms that are important
Table 2. Identification of Staphylococcus aureus cellular proteins disappeared after rhodomyrtone treatment.
Spot no. Accession no. Identified proteins Mw pI Mascot Sequence
(KDa) score coverage (%)
Amino acid and energy metabolisms
22 gi|15924300 glutamine-ammonia ligase 51108 5.09 137 5
34 gi|49484831 ornithine carbamoyltransferase 37867 5.15 42 37
43 gi|57651929 glycine dehydrogenase subunit 2
(decarboxylating)
54861 5.70 65 19
48 gi|156978879 2-amino-3-ketobutyrate coenzyme
A ligase
42935 5.14 79 43
53 gi|21283381 alanine dehydrogenase 40080 5.58 152 13
56.1 gi|49242958 carbamate kinase 35425 5.36 1086 35
56.2 gi|3892892 arginase 33170 5.29 165 8
61 gi|15925324 formimidoylglutamase 34605 5.35 53 7
62 gi|15923503 cysteine synthase (O-acetylserine
sulfhydrylase)-like protein
33012 5.39 289 40
65 gi|49484892 putative N-acetyltransferase 30603 5.26 299 38
Carbohydrate metabolism
17 gi|15924086 dihydrolipoamide dehydrogenase 49592 4.95 143 27
36 gi|49484802 fructose-1,6-bisphosphate aldolase 32893 4.96 46 28
40 gi|15924687 pyruvate kinase 63291 5.23 523 13
54 gi|221137774 glyceraldehyde 3-phosphate
dehydrogenase 2
37126 6.07 137 9
56.3 gi|15925514 D-lactate dehydrogenase 39297 5.35 57 2
70 gi|15923764 triosephosphate isomerase 27417 4.81 71 39
Cell wall biosynthesis and metabolism
13 gi|21282665 autolysin 137323 9.61 567 8
31.2 gi|15924634 GTPase ObgE 47263 5.05 190 11
71.2 gi|4948245 cell wall biosynthesis protein ScdA 25672 5.09 378 30
Lipid metabolism
31.1 gi|21282595 3-oxoacyl- synthase 43883 5.03 1125 49
Cell division
25 gi|15924176 cell division protein FtsZ 43135 4.74 523 32
Oxidative stress
78 gi|15924543 superoxide dismutase 22697 5.08 221 18
Pyrimidine metabolism
31.3 gi|15924191 dihydroorotase 46742 5.06 114 4
Protein degradation and Stress response
5 gi|15924570 DnaK protein 66378 4.65 538 17
79 gi|15923758 ATP-dependent Clp protease
proteolytic
21558 5.13 76 11
subunit-like protein
Surface antigen and virulence factor
71.3 gi|4948478 immunodominant antigen A 24198 6.11 189 15
Others
35 gi|49292908 putative hydrolase 30956 4.76 49 29
71.1 gi|4126674 hypothetical protein 22954 5.21 414 33
doi:10.1371/journal.pone.0016628.t002
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dependent Clp protease proteolytic subunit-like protein (ClpP,
proteolytic subunit) was suppressed whereas ATP-dependent Clp
proteinase chain (ClpB, ATPase subunit) was induced. In E. coli,
ClpB has a crucial function in cell survival at high temperatures
[45] and participates in de novo protein folding in mildly stressed
[46]. Our data suggested that MRSA responded to stress and
degradation of many intracellular proteins after exposure to
rhomyrtone at subinhibitory concentration. The compound also
inhibited the expression of immunodominant antigen A, a
virulence factor which elicits immune response during septicaemia
[47].
Effect of rhodomyrtone on S. aureus cell morphology
To elucidate the physiological effects of rhodomyrtone against
S. aureus, transmission electron microscopy was utilized. As
illustrated in Figure 3 and Figure 4, the micrographs clearly
demonstrated that the growth of both MRSA and S. aureus
ATCC 29213 in media containing rhodomyrtone at 0.174 mg/
ml for 18 h generated profound changes in both S. aureus cell
morphology and ultrastructure. Almost all rhodomyrtone-
treated cells were obviously affected on the cell envelope,
cytoplasmic contents, cell ultrastructure, and cell separation
process. Interestingly, we found that rhodomyrtone induced cell
wall deformation (Figure 3C), thickened cell wall (Figure 3D,
arrow), and thickened septa with irregular features (Figures 3E,
3F and 4E, arrows). Increasing in staphylococcal cell wall
thickness has been previously reported due to the mechanism of
actions of some antibiotics such as chloramphenicol [34],
erythromycin [48], penicillin [34], and vancomycin [49].
Furthermore, the arc-like shape of fibrillar wall material
occurring from turning of compressed cross wall and septal
formation (Figures 3E and 4E, arrows) were also observed in
rhodomyrtone exposed cells. This effect of the compound was
similar to staphylococcal cells grown in the presence of penicillin
at a concentration of 0.05 mg/ml [34]. After treatment with low
dose of penicillin, staphylococcal cells always affect the penicillin
binding protein which is considered to be located in the splitting
system [50]. Cell separation system is inhibited and only the
fibrillar wall material is organized instead of a compact cross
wall. The results might suggest that cells with thickened walls
may represent a defensive response to rhodomyrtone. Cells with
b r o k e nw a l l ,p r o t o p l a s t ,c e l lw a l ls h r e d s ,a n dc e l ld e b r i sw e r e
generally found following rhodomyrtone treatment (Figures 3C,
3 Fa n d4 C ,4 D ,4 F ) .I n d e e d ,v a r i o us atypical size and cell shape
alterations, for example, irregular, swollen, oval-shaped, and
defective cells were obviously noticeable, especially in the
treated MRSA (Figure 3C), while these aberrations were not
observed in the untreated control cells (Figure 4C). Overnight
exposure of S. aureus ATCC 29213 to rhodomyrtone resulted in
almost complete lysis of intact bacteria to cellular debris
( F i g u r e4 E ) .I nt h i ss t u d y ,r h o d o m y r t o n ew a sf o u n dt oc a u s e
cell wall and cytoplasmic membrane damage in S. aureus.
Meanwhile, it exhibited only insignificant morphological effects
to Streptococcus mutans using phase contrast microscopy, indistinct
enlarged cells have been detected after treatment with 5MIC
rhodomyrtone for 20 h [15].
In conclusion, our results from proteomic analysis demonstrated
consequences of the alterations of several cellular protein
expressions on MRSA and S. aureus cultures containing rhodo-
myrtone at subinhibitory concentration. Most differentially
expressed MRSA proteins belong to the functional categories
such as amino acid metabolism, carbohydrate metabolism, and
cell wall biosynthesis, suggesting that these might be the proteins
affected most by rhodomyrtone. Transmission electron micro-
graphs which revealed the morphological and ultrastructural
alterations of the treated cells supported the protein analysis data,
indicating that cell exposure to subinhibitory concentration of
rhodomyrtone for 18 h might involve damage of cell wall turnover
or membrane-related proteins.
The data reported in this paper support the understanding on
prominent antibacterial effects of rhodomyrtone that relate to cell
wall biosynthesis, cell membrane function, and cell division of
MRSA. The information shed light on the antimicrobial activities
of a new interest natural compound which might be a potential
candidate for a novel therapeutic agent for the treatment of
MRSA infections.
Materials and Methods
Preparation of ethanolic extract and rhodomyrtone
Dried leaves of R. tomentosa were extracted with 95% ethanol as
has been described previously [15]. Purification protocol and the
structure of rhodomyrtone, a major bioactive principle, have been
previously published by our research group [15,51]. Purity of
rhodomyrtone has been confirmed by referring to nuclear magnetic
resonance (NMR) and mass spectrometry (MS) reference [12,51].
Bacterial strains and growth conditions
MRSA NPRC 001R, a common endemic isolate with mecA gene
obtained from Hat Yai hospital, Thailand [52] and S. aureus
ATCC 29213 were used throughout this study. The bacterial
strains were stored as a 20% glycerol stock at 280uC until
required. Bacteria were precultured overnight from glycerol stock
on Luria-Bertani agar. The bacteria were inoculated into 2 ml of
trypticase soy broth at 37uC with constant shaking to mid-
exponential phase growth.
Determination of minimal inhibitory concentration (MIC)
MICs of the crude extract and rhodomyrtone against S. aureus
were carried out by a modified broth microdilution method
recommended by Clinical Laboratory Standardization Institute
(CLSI) guideline [53]. Two fold-serially dilution in a 96-well
microtiter plate of the extract and rhodomyrtone was prepared to
obtain final concentration ranged from 0.24 to 500 mg/ml and
0.0625 to 128 mg/ml, respectively. Briefly, an exponential phase
growth of S. aureus was diluted to a density of 10
8 cfu/ml in
CAMHB (Difco, Detroit, MI). The bacterial suspension was then
added to each well to provide a final inoculum density of
5610
5 cfu/ml. After incubation at 37uC for 16–18 h, the bacterial
suspension in each well was measured at OD600 nm against a blank
well (the broth containing 1% dimethyl sulphoxide, DMSO) with
an ELISA reader (Labsystems). The MIC was defined as the
lowest concentration of the agent that completely inhibited the
bacterial growth. All experiments were carried out in triplicate.
Time-kill study
Time-kill kinetic studies of the rhodomyrtone were performed in
cation-adjusted Mueller Hilton broth (CAMHB). An overnight
culture was used to inoculate in CAMHB containing rhodomyrtone
at 0.125, 0.25, 0.5, 1, and 2MIC. The initial inoculum was
approximately 10
8 cfu/ml. A culture containing 1% DMSO and
no rhodomyrtone was included in each assay as a growth control.
S a m p l i n gw a sd o n ea t0 ,1 ,2 ,3 ,4 ,5 ,6 ,8 ,1 8 ,a n d2 4h .V i a b l e
bacteria were determined by plate counts on Mueller Hilton agar.
The activity of rhodomyrtone was determined by plotting log10
colony count (cfu/ml) against time. Values shown are the means of
duplicate determinations from the experiments repeated three times.
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Staphylococcal cells were collected by centrifugation at 10,0006g
at 4uC for 20 min. The culture supernatant was removed and the
pellets were kept at -80uC until used. To prepare cellular proteins, the
lysate was washed twice with 0.85% (w/v) NaCl and resuspended in
phosphate buffer saline (PBS). The cells were agitated by a 750-Watt
Ultrasonic processor at 30% amplitude for 15 min on ice, pulse
durationsof9 sec on and 9 sec off.The lyzed cellswere centrifuged at
10,0006g at 4uC for 20 min to remove the cellular debris and
aggregate. Protein concentrations were quantified by Bradford
protein assay kit (Bio-Rad, Hercules, CA) according to the
manufacturer’s instruction. Bovine serum albumin (BSA) was used
as protein standard. The supernate containing solubilized proteins
w a su s e dd i r e c t l yo rs t o r e da t280uC until required.
SDS-PAGE
The protein samples were suspended in SDS sample buffer
(62.5 mM Tris (pH 6.8), 2% (w/v) SDS, 10% (v/v) glycerol, 5% (v/
v) mercaptoethanol, 0.05% (w/v) bromphenol blue) and heated at
100uC for 3–5 min prior to loading. Each 200 mg protein (5–10 ml)
was applied on acrylamide gels on MightyH Small II SE250 gel
apparatus (HoeferH Pharmacia Biotech). Proteins were separated
based on their molecular weight by electrophoresis at 25 mA
through a stacking gel (4% acrylamide) and a separating gel (12.5%
acrylamide). The gels were then stained by overnight incubation
with gentle agitation in staining solution (0.5% (w/v) Coomassie
Brilliant Blue G-250 in 20%(v/v) methanol,2% (v/v) O-phosphoric
acid, 8% (w/v) ammonium sulphate). Prestained protein ladder
(Bio-Rad) was used for SDS-PAGE molecular weight markers.
Western blot analysis
The method used was a modification of that described by
Towbin et al. [54]. The samples were run on 12.5% polyacryl-
amide gels and transferred onto nitrocellulose membrane
(Amersham bioscience) at 100V for 1 h in transfer buffer
(25 mM Tris-HCl (pH 8.3), 192 mM glycine, 10% (v/v) metha-
nol) using a Transblot unit (Bio-Rad). Nitrocellulose sheet was
blocked by incubating for 30 min in 5% (w/v) skim milk powder in
PBST (PBS with 0.05% (v/v) Tween-20), and followed by
incubation in mouse anti-S. aureus antiserum (1:3,000 dilution in
Figure 3. Transmission electron microscopy demonstrating the effects of rhodomyrtone on methicillin-resistant S. aureus NPRC
001R morphology and ultrastructure. The bacteria were incubated in CAMHB for 18 h, media containing 0.174 mg/ml of rhodomyrtone (C, D, E,
and F) and untreated control cultures (A and B). Scale bars=1 mm (A and C) and 0.5 mm (B, D, E, and F), respectively.
doi:10.1371/journal.pone.0016628.g003
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for 1–16 h. The antiserum was removed and the nitrocellulose
membrane was washed three times for 5 min in PBST with gentle
agitation. Horse radish peroxidase-conjugated goat anti-mouse
(Southern biotechnology) was added at a dilution of 1:3,000 in
PBST containing 0.2% (w/v) BSA and 0.2% (w/v) gelatin, and
incubated for 1–2 h with gentle agitation at room temperature.
The sheet was then washed four times in PBST and equilibrated in
67 mM phosphate buffer (pH 7.6). Antigen-antibody complexes
were detected by the addition of color detection solution (67 mM
phosphate buffer (pH 7.6) containing of 0.2% (w/v) 2,6-dichlor-
oinophenol and 0.03% hydrogen peroxide) and incubated in the
dark. The color reaction was stopped with deionized water.
Preparation of 2D-gel samples
The bacterial cell samples were prepared from four liter cultures
in the presence or the absence of subinhibitory concentration of
rhodomyrtone (0.174 mg/ml) after incubation for 18 h. Untreated
control cultures were grown in MHB containing 1% DMSO. The
pellets were then resuspended in standard cell lysis buffer (30 mM
Tris, 2 M thiourea, 7 M urea, 4% CHAPS) containing protease
inhibitors (Roche Diagnostics, Mannheim, Germany). Each
sample was subjected at 30% amplitude, 2 sec pulse-on, 2.5 sec
pulse-off, for a total of 5 min in an ice water bath. After sonication,
the lyzed cells were centrifuged and the supernatant was
transferred to a new tube. The pH of the homogenate was
adjusted to 8.5 by slow and careful addition of 50 mM sodium
hydroxide. The mixtures were stored in aliquots at 270uC until
required. The proteins were cleaned with 2D-Clean-up kit
(Amersham Biosciences) to eliminate detergents, salts, lipids,
phenolics, and nucleic acids. After the treatment, the samples
were solubilized with DeStreak Rehydration solution (Amersham
Biosciences). Protein concentrations were quantitated by 2D-
Quant kit (Amersham Biosciences) with BSA as the protein
standard before subjecting to isoelectric focusing.
2D-gel electrophoresis
To separate the cellular proteins in first dimension, the samples
(200–500 mg) in DeStreak Rehydration solution containing 1%
pH range of 3–10 immobilized pH gradient (IPG) buffer
Figure 4. Transmission electron microscopy demonstrating the effects of rhodomyrtone on S. aureus ATCC 29213 morphology and
ultrastructure. The bacteria were incubated in CAMHB for 18 h, media containing 0.174 mg/ml of rhodomyrtone (C, D, E, and F) and untreated
control cultures (A and B). Scale bars=1 mm (A and C) and 0.5 mm (B, D, E, and F), respectively.
doi:10.1371/journal.pone.0016628.g004
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the 7 or 18 cm strip holder of the IPG phor (GE Healthcare
Biosciences). The IPG strip (pH 3–10, non linear) (GE Healthcare
Biosciences) was placed into the strip holder containing the
sample. The PlusOne
TM DryStrip Cover Fluid (Amesham
Biosciences) was overlaid onto each IPG strips to prevent
evaporation and urea crystallization. The strip holder was then
placed into the Ettan IPG Phor Electrofocusing System (Amer-
sham Biosciences) and the IPG strip was allowed to rehydrate at
20uC for 12 h. The isoelectric focusing parameters were as
followed; the voltage was set at 300 V (Volt) until 200 Volt-hours
(Vh), 1,000 V until 300 Vh, 5,000 V until 4,000 Vh, and 5,000 V
until 2,000 Vh.
For the second dimension gel electrophoresis, each electro-
focused-IPG strip was equilibrated in 5 ml SDS-equilibration
buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 30% glycerol, 2%
SDS, and 0.002% bromphenol blue) containing 50 mg dithio-
threitol (DTT) for 15 min at room temperature. The strip was
then placed in 10 ml of the equilibration buffer containing 250 mg
iodoacetamide (IAA) for 15 min, washed by 1x electrode buffer,
and placed onto a 1 mm thick 12.5% polyacrylamide gel
(10611 cm
2) precasted in HoeferTMDual Gel Caster (Amersham
Biosciences). The second dimensional gel was carried out at
25 mA/gel until the tracking dye reached the lower edge of the
gel. After electrophoresis, the gel was subjected to colloidal
Coomassie brilliant blue staining. The molecular weight was
estimated according to the internal running calibration marker.
Image analysis
For visualization, gels were briefly rinsed with 1% acetic acid to
reduce background. The comparative analysis using ImageScan-
nerII and ImageMaster
TM Software (Amersham Biosciences) was
performed to detect differences in protein productions between gel
images of protein profiles obtained from rhodomyrtone-treated
cell proteins and the untreated cell proteins. Protein changes in
2D-gels were analyzed from three independent experiments
(biological replicates) and similar protein patterns were observed
among the gels. Unchanged expression of protein spot was
considered if protein intensity was less than two-fold (p.0.05).
Overexpressed or downregulated protein spots occurred after
rhodomyrtone treatment were excised recorded from representa-
tive gels. Selected spots that presented only in rhodomyrtone-
treated S. aureus samples and those that disappeared after the
treatment were individually excised from the respective Coomassie
dye stained-gels.
In-gel digestion and peptide extraction
Protein spots were destained using washing solution containing
50% methanol and 5% acetic acid in ultra deep water at 25uC for
18 h. Gel plugs were rinsed a few times in a period of 2–3 h with
fresh washing solution. The gel pieces were dehydrated with 100%
acetonitrile (ACN) and reduced with 10 mM DTT in 10 mM
ammonium bicarbonate at room temperature for 1 h. For
alkylation, 100 mM IAA in 10 mM ammonium bicarbonate was
added to the gel plugs and incubated at room temperature for 1 h
in the dark. After alkylation, the gel pieces were dehydrated twice
with 100% ACN for 5 min. To perform in-gel digestion of
proteins, 10 ml of trypsin solution (10 ng/ml trypsin in 50% ACN/
10 mM ammonium bicarbonate) were added to the gels and
incubated at room temperature for 20 min. After incubation,
20 ml of 30% ACN was added to keep the gels immersed
throughout digestion. The gels were incubated at 37uC for a few
hours or overnight. To extract peptide digestion products, 30 mlo f
50% ACN in 0.1% formic acid was added into the gels, and the
gels were then incubated at room temperature for 10 min in a
shaker. Extracted peptides were collected and pooled. The
peptides were dried by vacuum centrifuge and kept at 280uC
for further mass spectrometric analysis.
Matrix assisted laser desorption ionization–time of flight
mass spectrometry (MALDI-TOF/MS)
Identification of interested protein spots was performed using
MALDI-TOF/MS. The tryptic digests were spotted with a-cyano-
4-hydroxy-cinnamic acid (Sigma-Aldrich, St.Louis, MO) matrix
solution, and analyzed with an Ultraflex III MALDI-TOF/TOF
MS (Bruker Daltonics, Bremen, Germany). Mass spectra were
recorded in the positive-ion, delayed extraction mode. All spectra
were acquired with 20 kV accelerating voltage, 150 ns delayed
extraction time, and 900 Da low-mass gate. All spectra were
externally mass calibrated with ProteoMassTM Peptide and
Protein MALDI-MS Calibration Kit (Sigma-Aldrich).
Liquid chromatography-mass spectrometry (LC-MS)
The protein digests from rhodomyrtone-treated and untreated
MRSA were injected into Ultimate 3000 LC System (Dionex)
coupled to ESI-Ion Trap MS (HCT Ultra PTM Discovery System
[Bruker]) with electrospray at flow rate of 300 nl/min to a
nanocolumn (Acclaim PepMap 100 C18, 3 mm, 100A, 75 mm
id6150 mm). A solvent gradient (solvent A: 0.1% formic acid in
water; solvent B: 0.1% formic acid in 80% acetonitrile) was run in
40 min.
Database searching
All of the tandem mass spectra were analyzed against a public
database (National Center for Biotechnology Information) or
Swiss-Prot from MALDI fingerprint data by MASCOT (http://
www.matrixscience.com). Protein identification was performed on
the basis of statistically significant Mowse score (p,0.05).
Transmission electron microscopic analysis
Overnight cultures grown in the presence or the absence of
rhodomyrtone at 0.174 mg/ml were harvested by centrifugation at
10,0006g for 5 min. The cells were washed twice, resuspended in
PBS, and fixed with 2.5% glutaraldehyde in 0.1 M cacodylate.
The samples were then incubated at 4uC for at least 1 h. After
incubation, the cells were recovered by centrifugation at 10,0006g
for 5 min and washed twice with PBS. The pellets were fixed with
1% osmium tetraoxide and were then left at room temperature for
1 h. The samples were dehydrated with graded ethanol solutions
such as 30% ethanol for 10 min, 50% ethanol for 10 min, 70%
ethanol for 10 min, 90% ethanol for 10 min, and twice in 100%
ethanol for 15 min. They were fixed in Epon 812 resin and left to
polymerize for 3 days. Each sample was cut into thin slices,
approximately 90 nm, with a glass knife, stained with uranyl
acetate, and lead citrate on grids. Mophological and ultrastruc-
tural of the bacteria were observed and photographed by a Hitashi
H7000 at 75 kV.
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